Founders AND 3

Founders Fund is a San Francisco-based venture capital firm established in 2005, specializing in investments across various stages, from seed to later-stage funding. The firm targets companies that are developing transformative technologies in sectors such as consumer internet, biotechnology, artificial intelligence, aerospace, energy, and health. Founders Fund has a diverse investment portfolio, having backed notable companies like SpaceX, Facebook, and Palantir. The firm employs a founder-friendly investment approach, aiming to support entrepreneurs with minimal interference. With over $2 billion in capital under management, Founders Fund continues to seek innovative solutions to global challenges, making investments typically ranging from $500,000 to $300 million.

Delian Asparouhov

Principal

Jennifer Campbell

Partner

Lauren Gross

Partner and COO

Bridget Harris

Associate

Sean Liu

Partner

Jeffrey Lonsdale

Managing Director, Asia

John Luttig

Partner

Amin Mirzadegan

Partner

Scott Nolan

Partner

Neil Ruthven

CFO

Trae Stephens

Partner

Napoleon Ta

Partner

Matias Van Thienen

Partner

Past deals in Medical

MyOme

Series B in 2022
Myome helps identify genes that cause disease and act based on leading science. The data is secure, portable, and reusable throughout life.

9amHealth

Series A in 2022
9am.health redesigns all care elements into one digital service individualized around today’s reality of people’s life - always available and convenient, at prices anyone can afford even without insurance. 9am.health focuses on chronic conditions such as diabetes, hypertension, and hyperlipidemia for customers in the United States.

Alinea Saúde

Venture Round in 2022
Operator of a consumer digital health company designed to a combination of software, technology, and data science to supply consumers with information and access and provide better outcomes and cost-effective decisions. The company offers telehealth services, appointment bookings with the in-network physicians and specialists, enabling patients to have optimized healthcare without changing plans.

SmithRx

Series B in 2022
SmithRx is a pharmacy benefit manager based in San Francisco, California, that specializes in creating custom pharmacy benefit plans for companies to support their employees. Founded in 2016, the company employs a modern technology platform to enhance flexibility, efficiency, and customer satisfaction. SmithRx offers a cost-competitive pass-through model, a unified technology platform, and high-quality service guarantees related to drug costs and rebates. The firm’s in-house team comprises professionals with extensive experience from various healthcare companies and technology firms. Front-line clinicians play a key role in executing plans and providing member support. By leveraging technology and data analytics, SmithRx aims to redefine the pharmacy benefit landscape with a focus on precision and effectiveness.

Garner

Series B in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

SWORD Health

Series D in 2021
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.

9amHealth

Seed Round in 2021
9am.health redesigns all care elements into one digital service individualized around today’s reality of people’s life - always available and convenient, at prices anyone can afford even without insurance. 9am.health focuses on chronic conditions such as diabetes, hypertension, and hyperlipidemia for customers in the United States.

HeartLab

Seed Round in 2021
Developer of AI-based diagnostic tools designed to help doctors to diagnose and treat cardiovascular disease. The company's advanced deep learning-based tools facilitate doctors to gather more detail from an echocardiogram and automate the repetitive and time-consuming tasks involved in taking measurements from the tests, enabling doctors and clinicians to perform echocardiograms and interpret the results in very little time.

Calibrate

Series B in 2021
Calibrate Health, Inc. is a telemedicine startup focused on improving metabolic health to facilitate sustainable weight loss. Founded in 2019 and based in New York, the company offers a one-year metabolic reset program that integrates the latest scientific research on weight management. This program combines personalized medication with one-on-one coaching tailored to each individual's biology, goals, and lifestyle, aiming for a lasting weight reduction of at least 10%. Calibrate's platform is designed to drive physiological changes essential for effective obesity treatment, utilizing a value-based pricing model that emphasizes outcomes. Through telemedicine consultations and behavior change strategies, Calibrate empowers individuals to take control of their health and maintain long-term fitness.

Modern Animal

Series B in 2021
Modern Animal, Inc. operates a veterinary clinic that utilizes technology to enhance pet care services. Founded in 2018 and headquartered in Los Angeles, California, the company provides a range of offerings, including wellness exams, surgery, dentistry, and emergency care. It employs a membership model that grants clients access to unlimited exams, 24/7 virtual care, and convenient in-app prescription requests and delivery. Additionally, Modern Animal integrates advanced technology and design in both its clinics and mobile applications, allowing pet owners to book appointments online, manage medical records, and communicate directly with veterinary professionals. This approach aims to redefine the veterinary experience by fostering strong relationships between veterinarians, pets, and their owners while ensuring flexibility and personalized care.

Modern Animal

Series A in 2021
Modern Animal, Inc. operates a veterinary clinic that utilizes technology to enhance pet care services. Founded in 2018 and headquartered in Los Angeles, California, the company provides a range of offerings, including wellness exams, surgery, dentistry, and emergency care. It employs a membership model that grants clients access to unlimited exams, 24/7 virtual care, and convenient in-app prescription requests and delivery. Additionally, Modern Animal integrates advanced technology and design in both its clinics and mobile applications, allowing pet owners to book appointments online, manage medical records, and communicate directly with veterinary professionals. This approach aims to redefine the veterinary experience by fostering strong relationships between veterinarians, pets, and their owners while ensuring flexibility and personalized care.

Even

Seed Round in 2021
Even is a health tech company that collaborates with leading hospitals to provide comprehensive healthcare services through a subscription model. Its offerings include unlimited diagnostics, consultations, and hospitalization coverage valued at up to 50 lakh. The company simplifies the reimbursement process by directly transferring funds to partner hospitals, ensuring a seamless experience for members. By charging a recurring monthly fee, Even aims to address critical long-term health needs for individuals, making healthcare more accessible and manageable.

SWORD Health

Series C in 2021
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.

Maximus

Seed Round in 2021
Operator of a consumer health company intended to provide men with content, community, and clinical support to optimize them in mind and body. The company provides at-home lab tests and treatment, online group health coaching for nutrition, exercise, sleep, and focus, and also offers telemedicine and mail-order pharmacy services, enabling men to optimize their hormones and health.

Clearing

Seed Round in 2021
Relief Labs is a digitally native D2C platform that addresses healthcare issues.

Seed Health

Series A in 2021
Seed Health is a microbial sciences company focused on harnessing the applications of bacteria to enhance human and environmental health. Through collaborations with prominent academic institutions, the company accelerates scientific advancements to create live biotherapeutics and innovative consumer products. Its consumer brand, Seed®, specializes in developing next-generation probiotics tailored for various life stages and body ecosystems. The product offerings include supplements that combine probiotics and prebiotics aimed at providing systemic benefits, such as improving digestive health, skin health, heart health, and supporting micronutrient synthesis. The company's Scientific Advisory Board comprises experts in various fields, including microbiology, immunology, and gastroenterology, further strengthening its commitment to scientific rigor and innovation.

Seed Health

Series A in 2021
Seed Health is a microbial sciences company focused on harnessing the applications of bacteria to enhance human and environmental health. Through collaborations with prominent academic institutions, the company accelerates scientific advancements to create live biotherapeutics and innovative consumer products. Its consumer brand, Seed®, specializes in developing next-generation probiotics tailored for various life stages and body ecosystems. The product offerings include supplements that combine probiotics and prebiotics aimed at providing systemic benefits, such as improving digestive health, skin health, heart health, and supporting micronutrient synthesis. The company's Scientific Advisory Board comprises experts in various fields, including microbiology, immunology, and gastroenterology, further strengthening its commitment to scientific rigor and innovation.

Multiply Labs

Series A in 2021
Multiply Labs specializes in the manufacturing of personalized pharmaceutical capsules tailored to the specific needs of individual patients. By integrating pharmaceutical science with advanced robotics technology, the company has developed a unique robotic manufacturing facility that allows for the production of these capsules efficiently and cost-effectively. Multiply Labs is notable for being the first company to successfully introduce 3D printed capsules to the market, enabling the pharmaceutical industry to deliver medications that align with the unique metabolic requirements of patients.

Forward

Series D in 2021
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Modern Health

Series D in 2021
Modern Life Inc. is a mental health platform designed for companies that prioritize the emotional well-being of their workforce. Founded in 2017 and based in San Francisco, the platform offers a comprehensive suite of services including therapy, coaching, self-guided courses, and wellness resources. It features a network of certified coaches and licensed therapists available in multiple languages, along with tools such as wellness kits and assessments. Modern Life empowers employers to recognize the importance of mental health, promoting destigmatization and enhancing access to mental health services. The company aims to provide a holistic approach to well-being by addressing emotional, professional, social, financial, and physical health, ultimately fostering improved employee productivity and overall well-being.

Garner

Series A in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

SWORD Health

Series B in 2021
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.

Modern Health

Series C in 2020
Modern Life Inc. is a mental health platform designed for companies that prioritize the emotional well-being of their workforce. Founded in 2017 and based in San Francisco, the platform offers a comprehensive suite of services including therapy, coaching, self-guided courses, and wellness resources. It features a network of certified coaches and licensed therapists available in multiple languages, along with tools such as wellness kits and assessments. Modern Life empowers employers to recognize the importance of mental health, promoting destigmatization and enhancing access to mental health services. The company aims to provide a holistic approach to well-being by addressing emotional, professional, social, financial, and physical health, ultimately fostering improved employee productivity and overall well-being.

HeartLab

Seed Round in 2020
Developer of AI-based diagnostic tools designed to help doctors to diagnose and treat cardiovascular disease. The company's advanced deep learning-based tools facilitate doctors to gather more detail from an echocardiogram and automate the repetitive and time-consuming tasks involved in taking measurements from the tests, enabling doctors and clinicians to perform echocardiograms and interpret the results in very little time.

Siren Care

Series B in 2020
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.

Cedar

Series C in 2020
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and is headquartered in New York, New York.

Siren Care

Series B in 2020
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.

Siren Care

Series B in 2020
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.

Clara Health

Venture Round in 2020
Clara Health is a medical technology company that offers a software platform designed to facilitate patient participation in clinical trials. The platform simplifies the clinical trial process by assisting patients in navigating through various options, allowing them to filter and connect with relevant trials tailored to their needs. Additionally, Clara's technology supports crucial aspects of clinical trial management, including protocol design, site selection, and monitoring patient adherence. By placing the patient at the center of the process, Clara Health aims to enhance accessibility and engagement in clinical research.

SWORD Health

Series A in 2020
SWORD Health develops innovative technology solutions for the treatment of musculoskeletal disorders, allowing patients to engage in therapy from home. Founded in 2012 and headquartered in Porto, Portugal, the company combines licensed physical therapists with digital tools to provide effective care for chronic and post-surgical pain. Since its launch in 2015, SWORD Health has collaborated with insurers, health systems, and employers across Europe, Australia, and the United States, enabling thousands to access preventive and therapeutic musculoskeletal care. The company’s platform offers interactive rehabilitation exercises supervised by remote physiotherapists, facilitating independent use and reducing overall treatment costs. Through its mission to alleviate pain for two billion individuals, SWORD Health aims to transform the landscape of physical rehabilitation without relying on imaging, surgeries, or opioids. The company maintains offices in major cities, including New York City, Chicago, Salt Lake City, and Sydney.

Q Bio

Series B in 2020
Q Bio, Inc. is a healthcare technology company that has developed a clinically relevant whole body analytics platform aimed at providing comprehensive health assessments. Founded in 2015 and based in Redwood City, California, Q Bio combines advanced non-invasive imaging, genetics, biochemistry, vital signs, and an individual's medical history to create a detailed snapshot of health. Its Q BioVault platform analyzes this information within a 60-minute session, including a whole body MRI, to identify and track significant changes in a patient's health over time. By correlating various data sources, the platform automatically highlights critical health changes, helping to detect early stages of disease before symptoms manifest.

Modern Health

Series B in 2020
Modern Life Inc. is a mental health platform designed for companies that prioritize the emotional well-being of their workforce. Founded in 2017 and based in San Francisco, the platform offers a comprehensive suite of services including therapy, coaching, self-guided courses, and wellness resources. It features a network of certified coaches and licensed therapists available in multiple languages, along with tools such as wellness kits and assessments. Modern Life empowers employers to recognize the importance of mental health, promoting destigmatization and enhancing access to mental health services. The company aims to provide a holistic approach to well-being by addressing emotional, professional, social, financial, and physical health, ultimately fostering improved employee productivity and overall well-being.

Scanwell Health

Seed Round in 2019
Scanwell Health, Inc. is a healthcare company that specializes in designing and developing urine testing kits. The primary product, a urinary tract infection test kit, enables users to obtain clinical-grade results through their smartphones. In addition to test results, the kit connects users with an online doctor’s office for same-day treatment and prescription services. Established in 2018 and headquartered in Los Angeles, California, Scanwell Health has received FDA clearance for its urine testing application, underscoring its commitment to providing accessible and reliable healthcare solutions.

Modern Animal

Seed Round in 2019
Modern Animal, Inc. operates a veterinary clinic that utilizes technology to enhance pet care services. Founded in 2018 and headquartered in Los Angeles, California, the company provides a range of offerings, including wellness exams, surgery, dentistry, and emergency care. It employs a membership model that grants clients access to unlimited exams, 24/7 virtual care, and convenient in-app prescription requests and delivery. Additionally, Modern Animal integrates advanced technology and design in both its clinics and mobile applications, allowing pet owners to book appointments online, manage medical records, and communicate directly with veterinary professionals. This approach aims to redefine the veterinary experience by fostering strong relationships between veterinarians, pets, and their owners while ensuring flexibility and personalized care.
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company focused on developing oral biologic product candidates aimed at treating autoimmune, inflammatory, metabolic, and other diseases. The company utilizes a proprietary technology platform that enables the active transport of therapeutic agents across the intestinal epithelium, leveraging natural cellular trafficking pathways. Its lead candidate, AMT-101, is an oral gastrointestinal-selective interleukin 10 that has successfully completed a Phase 1b clinical trial for ulcerative colitis and is set to enter Phase 2 trials. Additionally, the company is advancing AMT-126, an oral fusion protein targeting intestinal epithelium barrier function defects. Applied Molecular Transport is dedicated to creating patient-friendly oral formulations, such as tablets and capsules, to enhance treatment accessibility and efficacy. Founded in 2010 and headquartered in South San Francisco, California, the company is building a diverse portfolio of therapeutic modalities, including peptides, proteins, antibodies, and RNA therapeutics.

Notable Labs

Series B in 2019
Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.

Notable Labs

Series B in 2019
Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.

Flo Health

Series A in 2019
Flo Health, Inc. specializes in developing menstruation cycle tracking solutions through its flagship product, Flo, an AI-driven women's health application. Founded in 2015 and headquartered in Redwood City, California, Flo provides comprehensive support for women at various stages of their reproductive health, including menstruation, conception, pregnancy, early motherhood, and menopause. The application leverages data science and artificial intelligence to offer personalized health insights, expert advice, and a secure community for users to share their experiences. Available in 20 languages on iOS and Android, Flo has gained significant popularity, with 30 million monthly active users and over 100 million installs globally. The app is recognized as the leading period tracker in the United States and the most downloaded female health app worldwide, reflecting its commitment to safety and its role as a trusted resource for women’s health information.

Hims

Series C in 2019
Hims, Inc. is an e-commerce brand focused on men's wellness, offering a range of products that address hair loss, sexual health, skincare, and oral care. The company collaborates with medical professionals to provide prescriptions for treatments such as Finasteride and Sildenafil through its online platform, enabling customers to receive diagnoses and treatments conveniently and at a lower cost. Founded in 2017 and based in San Francisco, Hims aims to fill the gap in the market for men's wellness products by providing straightforward solutions to common concerns. The company has also ventured into lifestyle products, including clothing and accessories. Hims was incubated by the venture-builder Atomic and has successfully secured significant funding to support its growth.

Siren Care

Series A in 2018
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company focused on developing oral biologic product candidates aimed at treating autoimmune, inflammatory, metabolic, and other diseases. The company utilizes a proprietary technology platform that enables the active transport of therapeutic agents across the intestinal epithelium, leveraging natural cellular trafficking pathways. Its lead candidate, AMT-101, is an oral gastrointestinal-selective interleukin 10 that has successfully completed a Phase 1b clinical trial for ulcerative colitis and is set to enter Phase 2 trials. Additionally, the company is advancing AMT-126, an oral fusion protein targeting intestinal epithelium barrier function defects. Applied Molecular Transport is dedicated to creating patient-friendly oral formulations, such as tablets and capsules, to enhance treatment accessibility and efficacy. Founded in 2010 and headquartered in South San Francisco, California, the company is building a diverse portfolio of therapeutic modalities, including peptides, proteins, antibodies, and RNA therapeutics.

SmithRx

Series A in 2018
SmithRx is a pharmacy benefit manager based in San Francisco, California, that specializes in creating custom pharmacy benefit plans for companies to support their employees. Founded in 2016, the company employs a modern technology platform to enhance flexibility, efficiency, and customer satisfaction. SmithRx offers a cost-competitive pass-through model, a unified technology platform, and high-quality service guarantees related to drug costs and rebates. The firm’s in-house team comprises professionals with extensive experience from various healthcare companies and technology firms. Front-line clinicians play a key role in executing plans and providing member support. By leveraging technology and data analytics, SmithRx aims to redefine the pharmacy benefit landscape with a focus on precision and effectiveness.

Hims

Series B in 2018
Hims, Inc. is an e-commerce brand focused on men's wellness, offering a range of products that address hair loss, sexual health, skincare, and oral care. The company collaborates with medical professionals to provide prescriptions for treatments such as Finasteride and Sildenafil through its online platform, enabling customers to receive diagnoses and treatments conveniently and at a lower cost. Founded in 2017 and based in San Francisco, Hims aims to fill the gap in the market for men's wellness products by providing straightforward solutions to common concerns. The company has also ventured into lifestyle products, including clothing and accessories. Hims was incubated by the venture-builder Atomic and has successfully secured significant funding to support its growth.

Cedar

Series B in 2018
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and is headquartered in New York, New York.

Virta Health

Series B in 2018
Virta Health operates an online specialty medical clinic focused on reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, the company combines nutritional biochemistry, clinical expertise, data science, and digital tools to develop its treatment protocols. Through its continuous remote care platform, Virta provides medical and behavioral support to patients, resulting in significant health improvements. In clinical trials, 60% of participants achieved diabetes reversal within one year, and 94% of insulin users were able to reduce or eliminate their insulin usage. The benefits of Virta's treatment extend to other aspects of metabolic and cardiovascular health, demonstrating sustained improvements in blood pressure, inflammation, liver function, and body mass index (BMI).

Siren Care

Seed Round in 2018
Siren Care, Inc. is a company that specializes in wearable health technology focused on diabetic foot health. Founded in 2015 and based in San Francisco, it has developed a unique diabetic foot monitoring system that includes specially designed socks made from a textile called Neurofabric. This material contains embedded microsensors that continuously monitor foot temperature, an early indicator of potential injuries that may lead to diabetic foot ulcers. By tracking temperature data, Siren's products enable users to detect signs of inflammation early, which is crucial for preventing serious complications such as amputations. The information collected by the smart socks can be monitored through an application, allowing healthcare providers to track their patients' conditions effectively. Siren Care serves both healthcare providers and patients, aiming to improve diabetic care and outcomes.

SmithRx

Series A in 2018
SmithRx is a pharmacy benefit manager based in San Francisco, California, that specializes in creating custom pharmacy benefit plans for companies to support their employees. Founded in 2016, the company employs a modern technology platform to enhance flexibility, efficiency, and customer satisfaction. SmithRx offers a cost-competitive pass-through model, a unified technology platform, and high-quality service guarantees related to drug costs and rebates. The firm’s in-house team comprises professionals with extensive experience from various healthcare companies and technology firms. Front-line clinicians play a key role in executing plans and providing member support. By leveraging technology and data analytics, SmithRx aims to redefine the pharmacy benefit landscape with a focus on precision and effectiveness.

Uniform Teeth

Seed Round in 2018
Uniform Teeth is an orthodontics practice focused on providing modern and accessible orthodontic care. The company operates dental clinics that specialize in clear teeth aligners, which are crafted from biocompatible, BPA-free plastic designed to fit the patient's teeth at each stage of treatment. By prioritizing quality and intuitiveness in their services, Uniform Teeth aims to simplify the orthodontic experience for patients seeking to straighten their teeth.

Cedar

Series A in 2017
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and is headquartered in New York, New York.

Counsyl

Venture Round in 2017
Counsyl is a health technology company specializing in DNA screening for individuals and families. Its services aim to provide critical health information that can influence important decisions regarding behavior, prevention, and preparedness for future health challenges. By leveraging advanced technology, including custom-built robotics and a team of scientists and engineers, Counsyl processes blood and saliva samples with high precision and efficiency. The company has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals, striving to make DNA screening accessible to a broad audience. Counsyl’s innovative approach has earned recognition, including the Wall Street Journal’s Innovation Award for Medicine, and its Family Prep Screen has significantly aided individuals in understanding crucial genetic information prior to childbearing. The platform has expanded its offerings to include informed pregnancy and cancer screening, emphasizing the integration of sophisticated technology in real-time communication of medical results between patients and healthcare providers.

Seed Health

Seed Round in 2017
Seed Health is a microbial sciences company focused on harnessing the applications of bacteria to enhance human and environmental health. Through collaborations with prominent academic institutions, the company accelerates scientific advancements to create live biotherapeutics and innovative consumer products. Its consumer brand, Seed®, specializes in developing next-generation probiotics tailored for various life stages and body ecosystems. The product offerings include supplements that combine probiotics and prebiotics aimed at providing systemic benefits, such as improving digestive health, skin health, heart health, and supporting micronutrient synthesis. The company's Scientific Advisory Board comprises experts in various fields, including microbiology, immunology, and gastroenterology, further strengthening its commitment to scientific rigor and innovation.

SmithRx

Seed Round in 2017
SmithRx is a pharmacy benefit manager based in San Francisco, California, that specializes in creating custom pharmacy benefit plans for companies to support their employees. Founded in 2016, the company employs a modern technology platform to enhance flexibility, efficiency, and customer satisfaction. SmithRx offers a cost-competitive pass-through model, a unified technology platform, and high-quality service guarantees related to drug costs and rebates. The firm’s in-house team comprises professionals with extensive experience from various healthcare companies and technology firms. Front-line clinicians play a key role in executing plans and providing member support. By leveraging technology and data analytics, SmithRx aims to redefine the pharmacy benefit landscape with a focus on precision and effectiveness.

Clara Health

Seed Round in 2016
Clara Health is a medical technology company that offers a software platform designed to facilitate patient participation in clinical trials. The platform simplifies the clinical trial process by assisting patients in navigating through various options, allowing them to filter and connect with relevant trials tailored to their needs. Additionally, Clara's technology supports crucial aspects of clinical trial management, including protocol design, site selection, and monitoring patient adherence. By placing the patient at the center of the process, Clara Health aims to enhance accessibility and engagement in clinical research.

Medal

Seed Round in 2016
Medal, Inc. is a healthcare company based in San Francisco, California, that specializes in the extraction, transportation, translation, and sharing of medical information. Founded in 2015, the company focuses on facilitating the review, coordination, referral, analysis, billing, and auditing of medical data to enhance efficiency in healthcare administration. As of July 2020, Medal operates as a subsidiary of CIOX Health, further strengthening its capabilities in the healthcare industry.

Q Bio

Seed Round in 2016
Q Bio, Inc. is a healthcare technology company that has developed a clinically relevant whole body analytics platform aimed at providing comprehensive health assessments. Founded in 2015 and based in Redwood City, California, Q Bio combines advanced non-invasive imaging, genetics, biochemistry, vital signs, and an individual's medical history to create a detailed snapshot of health. Its Q BioVault platform analyzes this information within a 60-minute session, including a whole body MRI, to identify and track significant changes in a patient's health over time. By correlating various data sources, the platform automatically highlights critical health changes, helping to detect early stages of disease before symptoms manifest.

Zocdoc

Series D in 2015
Zocdoc, Inc. owns and operates an online platform to search and book doctors' appointments. Additionally, it offers doctors’ reviews; appointment and preventive check-up reminders; and online paper-work services. The company focuses on chiropractors, dentists, dermatologists, eye doctors, gynecologists, primary care doctors, and psychiatrists. Zocdoc, Inc. was founded in 2007 and is headquartered in New York, New York.

Ringadoc

Venture Round in 2013
Ringadoc is a healthcare technology company that enhances communication between doctors and patients through a cross-platform software solution. The platform enables healthcare professionals to connect directly with patients, facilitating virtual consultations where medical advice can be provided, illnesses diagnosed, treatments advised, and prescriptions issued when necessary. By utilizing existing technologies and aligning with natural user behaviors, Ringadoc aims to simplify the healthcare experience for both providers and patients, ultimately fostering closer relationships in the virtual healthcare space. The company is led by Founder and CEO Jordan Michaels.

Practice Fusion

Series C in 2012
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California. Founded in 2005, it provides a practice management software platform that includes features such as charting, scheduling, billing, e-Prescribing, lab integrations, and secure messaging. The platform aims to connect a wide range of stakeholders in the healthcare ecosystem, including medical professionals, patients, labs, billers, imaging centers, and life science partners. Additionally, Practice Fusion offers Practice Fusion Insight, a healthcare database designed for medical professionals. The company serves a diverse clientele, including independent practices, small and large medical groups, community organizations, and non-profits. In 2018, Practice Fusion became a subsidiary of Allscripts Healthcare Solutions, further enhancing its capabilities in the electronic health records space.

MedTech Solutions

Venture Round in 2012
As of December 4, 2007, Med-Tech Solutions Inc. was acquired by The Four Rivers BioEnergy Company Inc. in a reverse merger transaction. Med-Tech Solutions, Inc., a development stage company, engages in the design, development, and marketing of specialty medical devices for the women’s health care industry in Canada. It has a license to manufacture, market, and distribute a medical pessary device called Gynecone, which is used for the treatment of female urinary incontinence. The company also designs pessary devices for the treatment of prolapsed tissue. Med-Tech Solutions was founded in 2004 and is based in Vancouver, Canada.

Counsyl

Private Equity Round in 2011
Counsyl is a health technology company specializing in DNA screening for individuals and families. Its services aim to provide critical health information that can influence important decisions regarding behavior, prevention, and preparedness for future health challenges. By leveraging advanced technology, including custom-built robotics and a team of scientists and engineers, Counsyl processes blood and saliva samples with high precision and efficiency. The company has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals, striving to make DNA screening accessible to a broad audience. Counsyl’s innovative approach has earned recognition, including the Wall Street Journal’s Innovation Award for Medicine, and its Family Prep Screen has significantly aided individuals in understanding crucial genetic information prior to childbearing. The platform has expanded its offerings to include informed pregnancy and cancer screening, emphasizing the integration of sophisticated technology in real-time communication of medical results between patients and healthcare providers.

Zocdoc

Series C in 2011
Zocdoc, Inc. owns and operates an online platform to search and book doctors' appointments. Additionally, it offers doctors’ reviews; appointment and preventive check-up reminders; and online paper-work services. The company focuses on chiropractors, dentists, dermatologists, eye doctors, gynecologists, primary care doctors, and psychiatrists. Zocdoc, Inc. was founded in 2007 and is headquartered in New York, New York.

Practice Fusion

Venture Round in 2011
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California. Founded in 2005, it provides a practice management software platform that includes features such as charting, scheduling, billing, e-Prescribing, lab integrations, and secure messaging. The platform aims to connect a wide range of stakeholders in the healthcare ecosystem, including medical professionals, patients, labs, billers, imaging centers, and life science partners. Additionally, Practice Fusion offers Practice Fusion Insight, a healthcare database designed for medical professionals. The company serves a diverse clientele, including independent practices, small and large medical groups, community organizations, and non-profits. In 2018, Practice Fusion became a subsidiary of Allscripts Healthcare Solutions, further enhancing its capabilities in the electronic health records space.

Practice Fusion

Series B in 2011
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California. Founded in 2005, it provides a practice management software platform that includes features such as charting, scheduling, billing, e-Prescribing, lab integrations, and secure messaging. The platform aims to connect a wide range of stakeholders in the healthcare ecosystem, including medical professionals, patients, labs, billers, imaging centers, and life science partners. Additionally, Practice Fusion offers Practice Fusion Insight, a healthcare database designed for medical professionals. The company serves a diverse clientele, including independent practices, small and large medical groups, community organizations, and non-profits. In 2018, Practice Fusion became a subsidiary of Allscripts Healthcare Solutions, further enhancing its capabilities in the electronic health records space.

Zocdoc

Series B in 2010
Zocdoc, Inc. owns and operates an online platform to search and book doctors' appointments. Additionally, it offers doctors’ reviews; appointment and preventive check-up reminders; and online paper-work services. The company focuses on chiropractors, dentists, dermatologists, eye doctors, gynecologists, primary care doctors, and psychiatrists. Zocdoc, Inc. was founded in 2007 and is headquartered in New York, New York.

Pathway Genomics

Series A in 2009
Pathway Genomics Corporation operates a clinical laboratory that offers a wide range of genetic testing services to physicians and patients both in the United States and internationally. Founded in 2008 and based in San Diego, California, the company specializes in areas such as liquid biopsy, hereditary cancer risk assessment, general health and wellness, pharmacogenomics, and carrier screening. Its testing portfolio includes services like CancerIntercept™ for detecting circulating tumor DNA, BRCATrue® and ColoTrue® for evaluating cancer risk, and tests designed to inform medication choices for mental health and pain management. Additionally, the company provides corporate wellness services and supports patients in making informed lifestyle decisions through tests such as PathwayFit® and Cardiac DNA Insight®. Pathway Genomics has established strategic partnerships to enhance its offerings, reflecting its commitment to advancing personalized medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.